drugset / Trial / NCT01561027
Crossover Study of CNV1014802 in Subjects With Neuropathic Pain From Lumbosacral Radiculopathy
RandomizedCrossoverTriple-blindTreatment
Summary
The study is a randomized, double blind, cross-over study to evaluate the safety and efficacy of CNV1014802 in subjects with neuropathic pain from lumbosacral radiculopathy.
Timeline
- Start
- 2011-04-30
- Primary completion
- 2012-06-30
- Completion
- 2012-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vixotrigine | Small molecule | 350 mg | — |